A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia.
Wiernik
P H
PH
Albert Einstein Cancer Center, Bronx, NY 10467.
Case
D C
DC
Periman
P O
PO
Arlin
Z A
ZA
Weitberg
A B
AB
Ritch
P S
PS
Todd
M B
MB
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage / Q000009:adverse effects; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D007958:Leukocyte Count / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D012074:Remission Induction
D003561:Cytarabine; D015255:Idarubicin; D003630:Daunorubicin